Aardvark Therapeutics Investors Have Deadline to Join Class Action

NEW YORK, Sept. 6, 2026 /CourierPR/ -- Rosen Law Firm, a global investor rights law firm, has reminded purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD) securities of a critical lead plaintiff deadline. According to the firm, the deadline for those who purchased Aardvark securities between February 13, 2025, and May 14, 2026, inclusive, to join the ongoing class action lawsuit is October 13, 2026.

The lawsuit alleges that Aardvark Therapeutics, Inc. made materially false and misleading statements in its Registration Statement and prospectus issued in connection with its initial public offering (IPO) on February 13, 2025. Specifically, the lawsuit claims that the company failed to disclose that its lead drug candidate, ARD-101, was less safe than it had led investors to believe. This, the lawsuit contends, overstated the drug's clinical, regulatory, and commercial prospects.

The lawsuit further alleges that Aardvark Therapeutics, Inc. failed to disclose the true safety profile of ARD-101 to investors, leading to materially false and misleading public statements. The firm suggests that when the true details of the situation became public, it caused a significant drop in the company's stock price, resulting in losses for investors.

Rosen Law Firm, which has achieved numerous significant victories in securities class action lawsuits, emphasizes the importance of selecting qualified counsel with a proven track record. The firm has been recognized for its success in leadership roles, having secured over $438 million for investors in 2019 alone. Rosen Law Firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has been ranked in the top four each year since 2013.

To join the class action, interested investors are encouraged to act promptly and file a case by the October 13, 2026, deadline. Investors who wish to serve as lead plaintiff can do so by moving the court by this date. If no lead plaintiff is appointed, the court will appoint one.

For more information, interested investors can visit the Rosen Law Firm's website or contact the firm directly. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.